Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J-Medivir Hepatitis C Drug Recommended by EU Regulator
Bloomberg
Friday, March 21, 2014 - 10:21am
tags:
JNJ, hepatitis C, Europe, Medivir, Olysio
Why GlaxoSmithKline plc's Investment Plans Should Thrust Earnings Skywards
Motley Fool
Friday, March 21, 2014 - 10:20am
tags:
GSK, earnings, R&D
Boehringer, Lilly Diabetes Drug Wins EU Panel’s Backing
Bloomberg
Friday, March 21, 2014 - 9:41am
tags:
Jardiance, diabetes, Boehringer Ingelheim, Eli Lilly, Europe
Endocyte's cancer drug meets main goal in lung cancer study
Yahoo/Reuters
Friday, March 21, 2014 - 9:38am
tags:
non-small cell lung cancer, Endocyte, vintafolide
Read This Twitter Chat About Gilead and the Cost of its Hep C Drug
TheStreet.com
Friday, March 21, 2014 - 9:02am
tags:
social media, twitter, hepatitis C, Sovaldi, Gilead Sciences, drug pricing
Transformational Late Stage Drugs Delivered Through Deal-Making
Forbes
Friday, March 21, 2014 - 8:54am
tags:
immuno-oncology
EMA committee backs conditional approval of Merck & Co., Endocyte's Vynfinit for ovarian cancer
First Word Pharma
Friday, March 21, 2014 - 8:50am
tags:
Europe, Merck, Endocyte, Vynfinit, ovarian cancer
Novartis CEO predicts generic industry fallout as quality takes center stage
Fierce Pharma Manufacturing
Friday, March 21, 2014 - 8:48am
tags:
Sandoz, Novartis, Joe Jimenez, generics, drug manufacturing
J&J blazes a new pharma trail with industry's first designer-in-chief
Fierce Pharma
Thursday, March 20, 2014 - 5:53pm
tags:
JNJ, product design
Apricus' Loss Narrows in Q4
Yahoo/Zacks.com
Thursday, March 20, 2014 - 5:51pm
tags:
Apricus Biosciences, earnings
Pay-for-delay: Is cash the only antitrust test that matters in patent settlements?
Fierce Pharma
Thursday, March 20, 2014 - 5:49pm
tags:
patents, pay-for-delay, antitrust, GSK, Lamictal, Teva Pharmaceutical
AstraZeneca unveils direct-to-patient Nexium sales to fend off generic rivals
Fierce Pharma
Thursday, March 20, 2014 - 5:48pm
tags:
AstraZeneca, DTC, Nexium, generics
OncoMed's Q4 Loss Narrows
Yahoo/Zacks.com
Thursday, March 20, 2014 - 5:46pm
tags:
earnings, OncoMed
Novo Nordisk sees chance of U.S. Tresiba launch before rival products
Yahoo/Reuters
Thursday, March 20, 2014 - 5:35pm
tags:
Novo Nordisk, insulin, diabetes, Tresiba, Lantus, Sanofi, Eli Lilly
Akebia, MediWound Post Gains Following IPOs
Wall St 24/7
Thursday, March 20, 2014 - 5:32pm
tags:
Akebia Therapeutics, IPOs, MediWound
FDA Clears Volcano Corp's iFR Modality
Yahoo/Zacks.com
Thursday, March 20, 2014 - 5:30pm
tags:
FDA, Volcano Corporation, devices, iFR modality
Is This Why Celgene Can’t Catch a Break?
Barron's
Thursday, March 20, 2014 - 5:28pm
tags:
Celgene, Otezla
Pharmacyclics Drug Imbruvica Beats Rivals: Nomura
Investors.com
Thursday, March 20, 2014 - 5:26pm
tags:
Imbruvica, Pharmacyclics, Gilead Sciences, Biogen Idec, chronic lymphocytic leukemia
Bayer Gets German Panel Request for Data on Cancer Drug Stivarga
Bloomberg
Thursday, March 20, 2014 - 5:23pm
tags:
Bayer, Stivarga, Germany, colorectal cancer
J&J gets $1.2 billion Arkansas Risperdal judgment tossed out
Yahoo/Reuters
Thursday, March 20, 2014 - 5:21pm
tags:
JNJ, Risperdal, Arkansas

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.